Evidence map›Paper›PMID 29843806›Full record

ArticleBMC systems biology2018

A computational framework for complex disease stratification from multiple large-scale datasets.

Bertrand De Meulder, Diane Lefaudeux, Aruna T Bansal, Alexander Mazein, Amphun Chaiboonchoe, Hassan Ahmed, Irina Balaur, Mansoor Saqi, Johann Pellet, Stéphane Ballereau and 23 more

Abstract read
In one paragraph

Article in BMC systems biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Systems Biology in Asthma.Advances in experimental medicine and biology · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Bertrand De MeulderEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France. bdemeulder@eisbm.org.ORCID 0000-0002-2108-7657
Diane LefaudeuxEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Aruna T BansalAcclarogen Ltd, St John's Innovation Centre, Cambridge, CB4 OWS, UK.
Alexander MazeinEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Amphun ChaiboonchoeEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Hassan AhmedEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Irina BalaurEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Mansoor SaqiEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Johann PelletEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Stéphane BallereauEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Nathanaël LemonnierEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France.
Kai SunData Science Institute, Imperial College, London, SW7 2AZ, UK.
Ioannis PandisData Science Institute, Imperial College, London, SW7 2AZ, UK.
Xian YangData Science Institute, Imperial College, London, SW7 2AZ, UK.
Manohara BatuwitageData Science Institute, Imperial College, London, SW7 2AZ, UK.
Kosmas KretsosUCB Pharma S.A, 1420, Braine-l'Alleud, Belgium.
Jonathan van EyllUCB Celltech, 208 Bath Road, Slough, SL13WE, UK.
Alun BeddingRoche Ltd, Welwyn Garden City, AL7 1TW, UK.
Timothy DavisonJanssen Research and Development Ltd, High Wycombe, HP12 4DP, UK.
Paul DodsonAstraZeneca Ltd, Alderley Park, Macclesfield, SK10 4TG, UK.
Christopher LarminieTarget Sciences, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK.
Anthony PostleFaculty of Medicine, University of Southampton, Southampton, SO17 1BJ, UK.
Julie CorfieldAstraZeneca R & D, 43150, Mölndal, Sweden.
Ratko DjukanovicFaculty of Medicine, University of Southampton, Southampton, SO17 1BJ, UK.
Kian Fan ChungNational Hearth and Lung Institute, Imperial College London, London, SW3 6LY, UK.
Ian M AdcockNational Hearth and Lung Institute, Imperial College London, London, SW3 6LY, UK.
Yi-Ke GuoData Science Institute, Imperial College, London, SW7 2AZ, UK.
Peter J SterkDepartment of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, AZ1105, The Netherlands.
Alexander MantaResearch Informatics, Roche Diagnostics GmbH, 82008, Unterhaching, Germany.
Anthony RoweJanssen Research and Development Ltd, High Wycombe, HP12 4DP, UK.
Frédéric BaribaudJanssen Research and Development Ltd, Spring House, PA, 19002, USA.
Charles AuffrayEuropean Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, EISBM, 50 Avenue Tony Garnier, 69007, Lyon, France. cauffray@eisbm.org.
U-BIOPRED Study Group and the eTRIKS Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultilevel data integration is becoming a major area of research in systems biology. Within this area, multi-'omics datasets on complex diseases are becoming more readily available and there is a need to set standards and good practices for integrated analysis of biological, clinical and environmental data. We present a framework to plan and generate single and multi-'omics signatures of disease states.

methodsThe framework is divided into four major steps: dataset subsetting, feature filtering, 'omics-based clustering and biomarker identification.

resultsWe illustrate the usefulness of this framework by identifying potential patient clusters based on integrated multi-'omics signatures in a publicly available ovarian cystadenocarcinoma dataset. The analysis generated a higher number of stable and clinically relevant clusters than previously reported, and enabled the generation of predictive models of patient outcomes.

conclusionsThis framework will help health researchers plan and perform multi-'omics big data analyses to generate hypotheses and make sense of their rich, diverse and ever growing datasets, to enable implementation of translational P4 medicine.

Indexed as

BiomarkersCluster AnalysisDiseaseFalse Positive ReactionsMachine LearningQuality ControlSystems BiologyBiomarkersMolecular signatures‘Omics dataStratificationSystems medicine

Identifiers

PMID29843806
PMCPMC5975674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.